These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24914743)

  • 1. Two novel mutations identified in a type 3 von Willebrand disease patient.
    Ouyang W; Yu Z; Yin J; Su J; Yang C; Ruan C
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):909-11. PubMed ID: 24914743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.
    Ahmad F; Budde U; Jan R; Oyen F; Kannan M; Saxena R; Schneppenheim R
    Thromb Haemost; 2013 Apr; 109(4):652-60. PubMed ID: 23407766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations.
    Jokela V; Lassila R; Szanto T; Joutsi-Korhonen L; Armstrong E; Oyen F; Schneppenheim S; Schneppenheim R
    Haemophilia; 2013 Nov; 19(6):e344-8. PubMed ID: 23834637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic basis of von Willebrand disease.
    Goodeve AC
    Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England.
    Sutherland MS; Keeney S; Bolton-Maggs PH; Hay CR; Will A; Cumming AM
    Haemophilia; 2009 Sep; 15(5):1048-57. PubMed ID: 19601990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.
    Bowman M; Tuttle A; Notley C; Brown C; Tinlin S; Deforest M; Leggo J; Blanchette VS; Lillicrap D; James P;
    J Thromb Haemost; 2013 Mar; 11(3):512-20. PubMed ID: 23311757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotype and genotype analysis of two Chinese pedigrees with type 3 von Willebrand diseases].
    Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Wang HL; Xi XD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct; 29(5):524-8. PubMed ID: 23042386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
    Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
    Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.
    Piétu G; Ribba AS; de Paillette L; Chérel G; Lavergne JM; Bahnak BR; Meyer D
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):415-21. PubMed ID: 1420817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease.
    Ahmed S; Yadegari H; Naz A; Biswas A; Budde U; Saqlain N; Amanat S; Tariq S; Raziq F; Masood S; Pavlova A; Shamsi TS; Oldenburg J
    Haemophilia; 2019 Nov; 25(6):1035-1044. PubMed ID: 31532876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population.
    Mohl A; Boda Z; Jager R; Losonczy H; Marosi A; Masszi T; Nagy E; Nemes L; Obser T; Oyen F; Radványi G; Schlammadinger Á; Szélessy ZS; Várkonyi A; Vezendy K; Vilimi B; Schneppenheim R; Bodó I
    J Thromb Haemost; 2011 May; 9(5):945-52. PubMed ID: 21362127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
    Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
    Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.
    Hawke L; Bowman ML; Poon MC; Scully MF; Rivard GE; James PD
    Blood; 2016 Jul; 128(4):584-93. PubMed ID: 27317792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.